Publications

• 03.29.2024  |  Addressing the Research and Development Gaps in Modern Phage Therapy Download
• 03.26.2024  |  Vaccine value profile for Klebsiella pneumoniae Download
• 11.01.2022  |  Gut microbiome dysbiosis in antibiotic-treated COVID-19 patients is associated with microbial translocation and bacteremia Download
• 11.01.2022  |  Antibiotic geographies and access to medicines: Tracing the role of India’s pharmaceutical industry in global trade Download
• 10.26.2022  |  Epidemiology of healthcare-associated infections and mechanisms of antimicrobial resistance of responsible pathogens in Ukraine: Results of a multicentre study (2019-2021) Download
• 10.19.2022  |  AMR CONTROL SUPPLEMENT THE CHALLENGE FOR THE CANCER COMMUNITY Download
• 10.17.2022  |  Assessment of the inclusion of vaccination as an intervention to reduce antimicrobial resistance in AMR national action plans: a global review Download
• 10.17.2022  |  Sustaining Action Against Antimicrobial Resistance : A Case Series of Country Experiences Download
• 09.23.2022  |  Antibiotic Arrivals in Africa: A Case Study of Yaws and Syphilis in Malawi, Zimbabwe and Uganda Download
• 08.25.2022  |  Development of light-activated hemithioindigo molecules to kill infectious bacteria Download
• 08.24.2022  |  First-of its-kind study of antimicrobial stewardship programs sheds light on how health systems can enhance care and reduce overuse of antibiotics Download
• 08.23.2022  |  Global antimicrobial resistance: a system-wide comprehensive investigation using the Global One Health Index Download
• 08.10.2022  |  The pandemic legacy of antimicrobial resistance in the USA Download
• 06.22.2022  |  Consumption of systemic antibiotics in India in 2019 Download
• 04.28.2022  |  Journal of Pharmaceutical Policy and Practice – India’s ban on antimicrobial fixed-dose combinations: winning the battle, losing the war? Download
• 04.26.2022  |  Antimicrobial Chemotherapy – Leaks in the Pipeline: a Failure Analysis of Gram-Negative Antibiotic Development from 2010 to 2020 Download
• 04.06.2022  |  Journal of Antimicrobial Chemotherapy – BSAC Vanguard Series: Why culture matters to tackle antibiotic resistance Download
• 01.20.2022  |  The Lancet – Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis Download
• 01.10.2022  |  Antimicrobial Agents and Chemotherapy – Analysis of the clinical pipeline of treatments for drug resistant bacterial infections: despite progress, more action is needed Download
• 11.01.2021  |  HealthAffairs – Estimating the appropriate size of global pull incentives for antibacterial medicines Download
• 10.20.2021  |  The National Academies Press – Combating Antimicrobial Resistance and Protecting the Miracle of Modern Medicine Download
• 10.07.2021  |  The Lancet Commission on diagnostics: transforming access to diagnostics Download
• 09.12.2021  |  Antibiotic resistance in the patient with cancer: Escalating challenges and paths forward Download
• 08.04.2021  |  ACS Infectious Diseases – The CARB-X Portfolio of Nontraditional Antibacterial Products Download
• 07.12.2021  |  Clinical Infectious Diseases – Patient access in fourteen high-income countries to new antibacterials approved by the FDA, EMA, PMDA, or Health Canada, 2010-2020 Download
• 06.23.2021  |  5 Years of CARB-X Progress – Addressing the Global Antibacterial Resistance Threat: Innovation to prepare for the future Download
• 03.23.2021  |  Stewardship and Access Plan Development Guide Download
• 03.23.2021  |  Indian Priority Pathogen List jointly developed by DBT and WHO India Office Download
• 01.25.2021  |  Clinical Infectious Diseases – Leveraging Vaccines to Reduce Antibiotic Use and Prevent Antimicrobial Resistance: a WHO Action Framework Download
• 01.02.2021  |  CDDEP – The State of the World’s Antibiotics 2021 – A Global Analysis of Antimicrobial Resistance and Its Drivers Download
• 11.11.2020  |  The Lancet – COVID-19 pneumonia and the appropriate use of antibiotics Download
• 10.23.2020  |  Nature – Improving data sharing to increase the efficiency of antibiotic R&D Download
• 10.11.2020  |  United States National Action Plan for Combating Antibiotic-Resistant Bacteria, 2020-2025 Download
• 06.25.2020  |  Clinical Infectious Diseases – Antibacterial R&D at a crossroads: We’ve pushed as hard as we can … now we need to start pulling! Download
• 06.19.2020  |  Innovation in Antimicrobial Resistance: The CARB-X Perspective Download
• 06.01.2020  |  Translational Research – Evaluating for-profit public benefit corporations as an additional structure for antibiotic development and commercialization Download
• 04.30.2020  |  A One Health framework to estimate costs of antimicrobial resistance Download
• 04.20.2020  |  Lancet Infectious Diseases – The Lancet Infectious Diseases Commission on antimicrobial resistance: 6 years later Download
• 01.30.2020  |  Clinical Infectious Diseases – Antibiotic development incentives that reflect societal value of antibiotics Download
• 11.19.2019  |  Nature Microbiology – The global preclinical antibacterial pipeline Download
• 11.19.2019  |  Nature Microbiology – Antibiotic development – economic, regulatory and societal challenges Download
• 10.30.2019  |  Lancet – A roadmap for sustainably governing the global antimicrobial commons Download
• 10.02.2019  |  Nature Biotechnology – A shot in the arm for new antibiotics Download
• 07.31.2019  |  Nature Communications – Designing development programs for non-traditional antibacterial agents Download
• 10.16.2018  |  PLOS ONE – Introduction and geographic availability of new antibiotics approved between 1999 and 2014 Download
• 10.01.2018  |  US National Action Plan for Combating Antibiotic-Resistant Bacteria: Progress Report: Year 3 – US Government CARB Task Force | Task Force provides an update on progress it is making on its 2015 commitment to slow the emergence of resistant bacteria and prevent the spread of resistant infections, strengthen national one-health surveillance, advance development and use of rapid diagnostic tests and characterization of resistant bacteria, accelerate basic and applied R&D for new antibiotics and other therapeutics, and improve international collaboration for prevention, surveillance, control and R&D. Download
• 07.17.2018  |  Journal of Law, Medicine, & Ethics – A Perspective on Incentives for Novel Inpatient Antibiotics: No One-Size-Fits-All Download
• 06.22.2018  |  World Economic Forum report in collaboration with Wellcome Trust: Not enough new antibiotics are in development to guarantee that we can continue to treat infections. This briefing outlines why pull incentives are necessary in addition to push funding, some of the key challenges they need to address and next steps towards implementing or piloting a pull incentive. Download
• 04.05.2018  |  J Pharm Policy Pract – Insights into early stage of antibiotic development in small- and medium-sized enterprises: a survey of targets, costs, and durations Download
• 01.15.2018  |  Drive-AB Report: Revitalizing the antibiotic pipeline Download
• 01.10.2018  |  Qualified Infectious Disease Product Designation Questions and Answers Guidance for Industry Download
• 11.21.2017  |  Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis Download
• 11.16.2017  |  BEAM Alliance Position Paper 2017 Key Guidelines to implement effective measures toward SMEs to revive the antibacterial R&D field Download
• 11.01.2017  |  Global Framework for Development & Stewardship to Combat Antimicrobial Resistance – Roadmap Download
• 10.24.2017  |  The Antibiotic Future Download
• 10.17.2017  |  The Value Added of the United Nations General Assembly High–Level Political Declaration on Antimicrobial Resistance Download
• 10.06.2017  |  Innovation in the preclinical antibiotic pipeline Download
• 09.08.2017  |  Disproportionate Exposure to Antibiotics in Children at Risk for Invasive Pneumococcal Disease: Potential for Emerging Resistance and Opportunity for Antibiotic Stewardship Download
• 07.01.2017  |  Antimicrobial resistance inWest Africa: a systematic review and meta-analysis Download
• 06.06.2017  |  To the G20: incentivising antibacterial research and development Download
• 05.15.2017  |  Incentives for New Drugs to Tackle Anti-Microbial Resistance Download
• 04.23.2017  |  We Will Miss Antibiotics When They’re Gone Download
• 03.15.2017  |  Antibiotic Resistance: More Information Needed to Oversee Use of Medically Important Drugs in Food Animals (GAO) Download
• 02.03.2017  |  Berlin Declaration of the G20 Health Ministers Download
• 02.03.2017  |  G20/OECD Focus Group Meeting on Antimicrobial Resistance Download
• 12.01.2016  |  Economic Incentives for Antibacterial Drug Development: Literature Review and Considerations From the Transatlantic Task Force on Antimicrobial Resistance Download
• 08.12.2016  |  Linking sustainable use policies to novel economic incentives to stimulate antibiotic research and development Download
• 07.29.2016  |  Accelerating global innovation to address antibacterial resistance: introducing CARB-X Download
• 06.14.2016  |  Delinking Investment in Antibiotic Research and Development from Sales Revenues: The Challenges of Transforming a Promising Idea into Reality. Download
• 05.31.2016  |  Progress in the Fight Against Multidrug-Resistant Bacteria? A Review of U.S. Food and Drug Administration–Approved Antibiotics. Download
• 05.15.2016  |  A Scientific Roadmap for Antibiotic Discovery Download
• 05.15.2016  |  Funding Antibiotic Innovation With Vouchers: RecommendationsOn How To Strengthen A Flawed Incentive Policy Download
• 11.18.2015  |  International cooperation to improve access to and sustain effectiveness of antimicrobials Download
• 08.01.2015  |  What Will It Take to Address the Global Threat of Antibiotic Resistance? Download
• 08.01.2015  |  Antibiotic Resistance: Journal of American Society of Law, Medicine & Ethics Download
• 06.01.2015  |  Responding to the Threat of Antimicrobial Resistance Download
• 02.26.2015  |  Repairing the Broken Market for Antibiotic Innovation Download
• 02.01.2015  |  An international legal framework to address antimicrobial resistance Download
• 02.01.2015  |  Business Model Options for Antibiotics – Learning from Other Industries Download
• 04.14.2014  |  Analytical Framework for Examining the Value of Antibacterial Products Download
• 02.15.2014  |  New Business Models for Sustainable Antibiotics Download
• 02.15.2012  |  Combating Antibiotic Resistance Through The Health Impact Fund Download
• 05.11.2011  |  Germ Shed Management in the United States Download
• 01.15.2011  |  Challenges of Antibacterial Discovery Download
• 11.20.2010  |  Improving antibiotic markets for long term stability Download
• 11.15.2010  |  Superbugs call for super changes in drug-sale rules Download
• 09.01.2010  |  Fighting Antibiotic Resistance: Marrying New Financial Incentives To Meeting Public Health Goals Download
• 08.01.2007  |  Will longer antimicrobial patents improve public health? Download